西安康拓医疗技术股份有限公司2025年第二次临时股东会决议公告

Group 1 - The core point of the announcement is the resolution of the second extraordinary general meeting of shareholders held by Xi'an Kangtuo Medical Technology Co., Ltd. on September 16, 2025, with no rejected proposals [1][2]. - The meeting was convened by the board of directors and chaired by Chairman Hu Liren, utilizing a combination of on-site and online voting methods, in compliance with the Company Law of the People's Republic of China and the company's articles of association [2][3]. - A total of 9 directors were in office, with 7 attending the meeting, including 4 participating via communication methods, and the board secretary and financial director also attended [3]. Group 2 - Two ordinary resolution proposals were reviewed and approved: the profit distribution plan for the first half of 2025 and the proposal to provide financial assistance to affiliated companies [4][5]. - Both proposals received more than half of the voting rights held by shareholders or their proxies present at the meeting, with separate counting for minority investors [5]. - The meeting was witnessed by lawyers from Guohao Law Firm (Xi'an), who confirmed that the convening and proceedings of the meeting complied with relevant laws and regulations [5].